Moreover, systemic administration of VEGF‐C156S effectively attenuated TAC stress‐induced cardiac edema and hypertrophy, thereby improving cardiac dysfunction as detected by echocardiography and invasive LV PV analysis. This evidence concerns the gene VEGFA and persistent truncus arteriosus.